MECHANICSBURG, Pa., July 26, 2017 /PRNewswire/ -- BeneCard PBF, a leader in providing clinical solutions that address
BenePrecise utilizes precision medicine, which evaluates and considers a patient's metabolism, environment and lifestyle, to develop effective, individualized treatment plans. Through BenePrecise, BeneCard PBF's pharmacists work with members and their prescribers to coordinate changes in drug therapies, as indicated by pharmacogenetic testing. This ensures that members receive the most clinically appropriate and effective medications. By proactively identifying which drug therapies will not work, or are likely to cause severe adverse reactions, clients and their members can avoid unnecessary risks and expenses.
"We are excited to offer our BenePrecise program," says Jennifer Fuhrmann, PharmD and Vice President of Clinical Services for BeneCard PBF. "Pharmacogenetic testing can have a measurable positive impact for members who live with chronic health challenges such as diabetes or high cholesterol. Our pharmacists can help them move quickly onto the most appropriate drug therapy and improve their health with fewer side effects and less risk, based on their unique metabolism."
There are no doctor's visits required to administer the test. Members can collect and submit the sample from home using a simple cheek swab. The markers identified by pharmacogenetic testing do not change over a member's lifetime, so repeat tests are not required.
BenePrecise enables a personalized approach to care aimed at reducing costs, improving treatment efficacy and preventing adverse drug reactions.
About BeneCard PBFThrough pharmacogenetics and proactive clinical programs, BeneCard PBF enhances patient outcomes while lowering prescription drug costs. With offices in Florida, Pennsylvania and New Jersey, BeneCard PBF administers fixed-rate and self-funded prescription benefit programs. The company offers innovative solutions to control costs while providing the highest quality service available in prescription benefit management.
View original content:http://www.prnewswire.com/news-releases/innovative-pbm-introduces-pharmacogenetics-offering-300494187.html
SOURCE BeneCard PBF
Subscribe to our Free Newsletters!
Necrotizing fasciitis is a rare life threatening bacterial infection of the tissue below the skin ...
Menstruation or period is the discharge of blood and mucus called menses from the uterus via the ...
Chronic dieting is associated with eating disorders that mainly include unhealthy eating practices ...View All